BIOTRONIK Blog Explore our latest insightful interviews and articles Image Blog Stories Filter and Search Filter by year - Any -20242023202220212020 Filter by category - Any -3D Mapping60 YearsAblationAcutus MedicalAlCath ForceAmviaAngioplastyAsia Pacific Manufacturing and Research HubAtrial FibrillationAutoAdaptBalloon CatheterBetter ClimateBIO REACTBIO-LIBRABioEnvelopeBIOFLEX-IBIOFLOWBIOFLOW-VBIOHELIXBIOLIBRABIOLUXBIOMAGBIOMAG-IBIOMONITORBIOMONITOR IIIBIOMONITOR IIImBIONETIC-IBIOPACTBIOSOLVEBIOSOLVE-IVBIOSTEMIBIOTRONIK CanadaBIOTRONIK JapanBIOTRONIK Patient AppBIOTRONIK USBIOWOMENBlogBradycardiaBurnoutCanadaCardiac ArrestCardiac DevicesCardiac ImplantCardiac Rhythm ManagementCardiologyCardiology InsightsCardioSphereCardiovascular DiseaseCardiovascular HealthCareerCASTLE-AFCatheterCE ApprovalCertificationCharing CrossChineseChronic PainCIRSEClinical StaffClinical StudiesClinical Trials DayClinicsClosed Loop StimulationCLSCode of Business ConductCompany CultureCompany MilestoneCompany ValuesComplianceConduction System PacingCoronaryCoronary Artery DiseaseCorporateCorporate Social ResponsibilityCOVID-19CPRCRMCRTCRT-DCRT-PCryptogenic StrokeCSPCSRCybersecurityCzechData ProtectionDCBDESdiagnosticsDietDigital HealthDonationDREAMS 3GDrug-Coated BalloonDX TechnologyDynetic-35EdoraEHRAElectromagnetic FieldsElectrophysiologyEmployee EngagementEmployee WellbeingEndovascular ProceduresEnvironmentEqual RepresentationEqualityESC CongressespanaespanolEthicsEuroPCREuropean UnionEventEvityExcerciseFDA ApprovalFirst ImplantFoodFortressFrenchGDPRGoldTipHBPHealth & WellnessHealth DataHealth InitiativeHealth TipsHeartHeart AttacksHeart FailureHeart HealthHeartInsightHemodialysisHis Bundle PacingHistoryHome MonitoringHuman RightsICDImplantable Cardiac MonitorIN-TIMEInside BIOTRONIKInternational Women's DayInterventional CardiologyInterviewInticaIntroducer SheathsJapanLaunchLBBAPLINCMagmarisMaking A DifferenceManufacturingMarathonMATRIX StudyMATRIX studyMDRMental HealthMoMeMonitoringMRIMultiPole PacingMyocardial InfarctionSustainabilityNeuro NewsNeurologyNeuromodulationNew Year's ResolutionsNursesOccupational SafetyOrsiroOrsiro MissionOscarpacemakerPacemakerPacemakerspacemakersPAD TreatmentPasseoPasseo-18 LuxPasseo-35 XeoPatient AppPatient CarePatient DayPatient QuestionsPatient SafetyPatientsPCIPeripheralPhysician Well-BeingPK PapyrusPlexaPollutionportuguesportuguesePortuguesePRPress releasePress ReleasePRO-KineticProMRIPulsarPulsar-18Pulsar-18 T3QP ExCELsR&DRadiationREACT DXReading RecommendationRehabilitationReimbursementRelativesRemote cardiac monitoringRemote Careremote monitoringRemote MonitoringResearchResorbable Magnesium ScaffoldResorbale ScaffoldsRhythmCheckRivacorRMSSafetyScaffoldScansScienceSCSSelectra 3DSELENE HFSENSESentusSingaporeSmall Coronary VesselsSmartphoneSoftwareSpainSpanishspanishSportsStatementSTEMIStentStoryStrokeStudiesStudystudySupply ChainSyncopeTachycardiaTCTTelemedicineTHINGSTIMELYTraining & EducationTravelTRCTrendsTrialTRUECOINUKVacationVascular InterventionVIWebinarwebinarWomenWomen in CardiologyWorkflowZero-Gravity Search 49 blog articles Image March 7, 2024 Blog Improving Cardiovascular Health This International Women’s Day Image February 14, 2024 Blog How Love Benefits Your Heart Health Exploring the Science Behind Love's Cardiovascular Benefits Image January 31, 2024 Blog BIOTRONIK Employees Donate Over 14,000 Euros to the Arche Berlin-Hellersdorf A Donation Ceremony Took Place at the Woermannkehre, on January 18, 2024 Image December 22, 2023 Blog Gold Standard for Two Decades: Why the Use of GoldTip is Still Unbeaten in Certain Ablation Procedures In the midst of celebrating 60 years of service in partnership with the healthcare community, BIOTRONIK’s Electrophysiology business marked another important milestone of its own in 2023 – its 20 th anniversary. Image December 12, 2023 Blog 60 Years of Saving Lives – How the BIOTRONIK Mission Continues 2023 was a landmark year for BIOTRONIK – not simply in name or number – but in action. The company’s 60 th year of operations was a busy one for lifesaving innovations like the Amvia pacemaker and CRT-P family and Oscar catheter, to laying the groundwork for helping a whole new community of patients with the Prospera TM spinal cord stimulation system, a BIOTRONIK first. Image December 11, 2023 Blog Vascular Revolution Spurs Overdue Update to Radiation Guidelines Prof. Anders Wanhainen Highlights New ESVS Recommendations, Advising on Suspended Personal Radiation Protection Systems for the First Time Image November 24, 2023 Blog 60 Years of Saving Lives – How the BIOTRONIK Mission Spread Globally What began with one lifesaving mission between two students in early 1960s Berlin now spans the globe: BIOTRONIK is active in more than 100 countries. Image October 20, 2023 Blog Unveiling Hidden Atrial Fibrillation: Implications for Stroke Prevention in ICD Patients New Research Confirms Effective Tools to Better Protect Patients with High Stroke Risk Image October 18, 2023 Blog 60 Years of Saving Lives – How the BIOTRONIK Mission Began This year is a special year for BIOTRONIK, one in which we mark sixty years of service in the healthcare community. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Next page Next › Subscribe for our News You must have JavaScript enabled to use this form. Title Select TitleMsMrMXDrProf First name Last name Role Please select your roleHealthcare ProfessionalPatient or RelativeJournalistOther Email Phone Country/Region - Select -AfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua & BarbudaArgentinaArmeniaArubaAscension IslandAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBosnia & HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBritish Virgin IslandsBruneiBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCanary IslandsCape VerdeCaribbean NetherlandsCayman IslandsCentral African RepublicCeuta & MelillaChadChileChinaChristmas IslandClipperton IslandCocos (Keeling) IslandsColombiaComorosCongo - BrazzavilleCongo - KinshasaCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzechiaCôte d’IvoireDenmarkDiego GarciaDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard & McDonald IslandsHondurasHong Kong SAR ChinaHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKosovoKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacao SAR ChinaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmar (Burma)NamibiaNauruNepalNetherlandsNetherlands AntillesNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorthern Mariana IslandsNorth KoreaNorth MacedoniaNorwayOmanOutlying OceaniaPakistanPalauPalestinian TerritoriesPanamaPapua New GuineaParaguayPeruPhilippinesPitcairn IslandsPolandPortugalPuerto RicoQatarRomaniaRussiaRwandaRéunionSamoaSan MarinoSarkSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia & South Sandwich IslandsSouth KoreaSouth SudanSpainSri LankaSt. BarthélemySt. HelenaSt. Kitts & NevisSt. LuciaSt. MartinSt. Pierre & MiquelonSt. Vincent & GrenadinesSudanSurinameSvalbard & Jan MayenSwedenSwitzerlandSyriaSão Tomé & PríncipeTaiwanTajikistanTanzaniaThailandTimor-LesteTogoTokelauTongaTrinidad & TobagoTristan da CunhaTunisiaTurkmenistanTurks & Caicos IslandsTuvaluTürkiyeU.S. Outlying IslandsU.S. Virgin IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVatican CityVenezuelaVietnamWallis & FutunaWestern SaharaYemenZambiaZimbabweÅland Islands Topic Please select a topicProductsPatientsHealthcare Professionals I prefer to be contacted by Phone Email Message *Fields are mandatory. Latest Press Releases Show all press releases Image July 11, 2024 MONTREAL, Canada Press Release Amvia Sky Launched in Canada, the World’s First Pacemaker Approved for LBBAP* Dr. Fadi Mansour performed the first Canadian implant of BIOTRONIK’s newest pacemaker and CRT-P generation earlier this year at the Centre Hospitalier de l'Université de Montréal. The patient received an Amvia Sky HF-T QP triple chamber pacemaker device. The first implant follows the full market release of BIOTRONIK’s newest family of pacemaker and CRT-P devices, featuring patient-centric technologies for better patient care and simplified workflows. “The Amvia Sky HF-T QP offers a significant number of advanced features, making it the most complete CRT-P on the market including streamlined Image July 1, 2024 BUELACH, SWITZERLAND Press Release BIOTRONIK Introduces Expanded Maximum Diameter Dimensions for Orsiro Mission DES BIOTRONIK is pleased to announce the availability of an expanded Maximum Allowed Diameters (MAD) range for the Orsiro® Mission Drug Eluting Stent (DES). Diameters 2.25mm to 3.00mm of the Orsiro Mission DES can now be extended up to 4.0mm, while diameters 3.5mm and 4.0mm can reach up to 5.0mm. This new MAD expansion follows the approvals from CE, FDA, and Health Canada obtained in the past months. This update reflects a global effort for the Orsiro Mission stent technology to match contemporary Percutaneous Coronary Intervention (PCI), enabling practitioners to optimize vessel apposition and Image May 30, 2024 BUELACH, SWITZERLAND Press Release One-Year BIONETIC-I Study Results Show Safety and Effectiveness of Iliac Artery Treatment With BIOTRONIK’s Dynetic-35 Cobalt Chromium Balloon-Expandable Stent System BIOTRONIK announced the presentation of the 12-month results from the BIONETIC-I study this week at LINC 2024. The prospective, international, multicenter single-arm observational study evaluated the treatment of de novo, restenotic or occluded iliac lesions in 160 patients with Rutherford Class 2-6 peripheral artery disease using the Dynetic ®-35 cobalt chromium balloon-expandable stent system. At baseline, 12.5% of enrolled patients had critical limb ischemia, 90% had calcified lesions (30.7% severe calcification), and there was an average of 85.5% stenosis in the target lesion. The primary Press Contact Corporate Public Relations & Communications press@biotronik.com +49 (0) 30 68905 1414 Get in contact
Image February 14, 2024 Blog How Love Benefits Your Heart Health Exploring the Science Behind Love's Cardiovascular Benefits
Image February 14, 2024 Blog How Love Benefits Your Heart Health Exploring the Science Behind Love's Cardiovascular Benefits
Image January 31, 2024 Blog BIOTRONIK Employees Donate Over 14,000 Euros to the Arche Berlin-Hellersdorf A Donation Ceremony Took Place at the Woermannkehre, on January 18, 2024
Image January 31, 2024 Blog BIOTRONIK Employees Donate Over 14,000 Euros to the Arche Berlin-Hellersdorf A Donation Ceremony Took Place at the Woermannkehre, on January 18, 2024
Image December 22, 2023 Blog Gold Standard for Two Decades: Why the Use of GoldTip is Still Unbeaten in Certain Ablation Procedures In the midst of celebrating 60 years of service in partnership with the healthcare community, BIOTRONIK’s Electrophysiology business marked another important milestone of its own in 2023 – its 20 th anniversary.
Image December 22, 2023 Blog Gold Standard for Two Decades: Why the Use of GoldTip is Still Unbeaten in Certain Ablation Procedures In the midst of celebrating 60 years of service in partnership with the healthcare community, BIOTRONIK’s Electrophysiology business marked another important milestone of its own in 2023 – its 20 th anniversary.
Image December 12, 2023 Blog 60 Years of Saving Lives – How the BIOTRONIK Mission Continues 2023 was a landmark year for BIOTRONIK – not simply in name or number – but in action. The company’s 60 th year of operations was a busy one for lifesaving innovations like the Amvia pacemaker and CRT-P family and Oscar catheter, to laying the groundwork for helping a whole new community of patients with the Prospera TM spinal cord stimulation system, a BIOTRONIK first.
Image December 12, 2023 Blog 60 Years of Saving Lives – How the BIOTRONIK Mission Continues 2023 was a landmark year for BIOTRONIK – not simply in name or number – but in action. The company’s 60 th year of operations was a busy one for lifesaving innovations like the Amvia pacemaker and CRT-P family and Oscar catheter, to laying the groundwork for helping a whole new community of patients with the Prospera TM spinal cord stimulation system, a BIOTRONIK first.
Image December 11, 2023 Blog Vascular Revolution Spurs Overdue Update to Radiation Guidelines Prof. Anders Wanhainen Highlights New ESVS Recommendations, Advising on Suspended Personal Radiation Protection Systems for the First Time
Image December 11, 2023 Blog Vascular Revolution Spurs Overdue Update to Radiation Guidelines Prof. Anders Wanhainen Highlights New ESVS Recommendations, Advising on Suspended Personal Radiation Protection Systems for the First Time
Image November 24, 2023 Blog 60 Years of Saving Lives – How the BIOTRONIK Mission Spread Globally What began with one lifesaving mission between two students in early 1960s Berlin now spans the globe: BIOTRONIK is active in more than 100 countries.
Image November 24, 2023 Blog 60 Years of Saving Lives – How the BIOTRONIK Mission Spread Globally What began with one lifesaving mission between two students in early 1960s Berlin now spans the globe: BIOTRONIK is active in more than 100 countries.
Image October 20, 2023 Blog Unveiling Hidden Atrial Fibrillation: Implications for Stroke Prevention in ICD Patients New Research Confirms Effective Tools to Better Protect Patients with High Stroke Risk
Image October 20, 2023 Blog Unveiling Hidden Atrial Fibrillation: Implications for Stroke Prevention in ICD Patients New Research Confirms Effective Tools to Better Protect Patients with High Stroke Risk
Image October 18, 2023 Blog 60 Years of Saving Lives – How the BIOTRONIK Mission Began This year is a special year for BIOTRONIK, one in which we mark sixty years of service in the healthcare community.
Image October 18, 2023 Blog 60 Years of Saving Lives – How the BIOTRONIK Mission Began This year is a special year for BIOTRONIK, one in which we mark sixty years of service in the healthcare community.
Image July 11, 2024 MONTREAL, Canada Press Release Amvia Sky Launched in Canada, the World’s First Pacemaker Approved for LBBAP* Dr. Fadi Mansour performed the first Canadian implant of BIOTRONIK’s newest pacemaker and CRT-P generation earlier this year at the Centre Hospitalier de l'Université de Montréal. The patient received an Amvia Sky HF-T QP triple chamber pacemaker device. The first implant follows the full market release of BIOTRONIK’s newest family of pacemaker and CRT-P devices, featuring patient-centric technologies for better patient care and simplified workflows. “The Amvia Sky HF-T QP offers a significant number of advanced features, making it the most complete CRT-P on the market including streamlined
Image July 11, 2024 MONTREAL, Canada Press Release Amvia Sky Launched in Canada, the World’s First Pacemaker Approved for LBBAP* Dr. Fadi Mansour performed the first Canadian implant of BIOTRONIK’s newest pacemaker and CRT-P generation earlier this year at the Centre Hospitalier de l'Université de Montréal. The patient received an Amvia Sky HF-T QP triple chamber pacemaker device. The first implant follows the full market release of BIOTRONIK’s newest family of pacemaker and CRT-P devices, featuring patient-centric technologies for better patient care and simplified workflows. “The Amvia Sky HF-T QP offers a significant number of advanced features, making it the most complete CRT-P on the market including streamlined
Image July 1, 2024 BUELACH, SWITZERLAND Press Release BIOTRONIK Introduces Expanded Maximum Diameter Dimensions for Orsiro Mission DES BIOTRONIK is pleased to announce the availability of an expanded Maximum Allowed Diameters (MAD) range for the Orsiro® Mission Drug Eluting Stent (DES). Diameters 2.25mm to 3.00mm of the Orsiro Mission DES can now be extended up to 4.0mm, while diameters 3.5mm and 4.0mm can reach up to 5.0mm. This new MAD expansion follows the approvals from CE, FDA, and Health Canada obtained in the past months. This update reflects a global effort for the Orsiro Mission stent technology to match contemporary Percutaneous Coronary Intervention (PCI), enabling practitioners to optimize vessel apposition and
Image July 1, 2024 BUELACH, SWITZERLAND Press Release BIOTRONIK Introduces Expanded Maximum Diameter Dimensions for Orsiro Mission DES BIOTRONIK is pleased to announce the availability of an expanded Maximum Allowed Diameters (MAD) range for the Orsiro® Mission Drug Eluting Stent (DES). Diameters 2.25mm to 3.00mm of the Orsiro Mission DES can now be extended up to 4.0mm, while diameters 3.5mm and 4.0mm can reach up to 5.0mm. This new MAD expansion follows the approvals from CE, FDA, and Health Canada obtained in the past months. This update reflects a global effort for the Orsiro Mission stent technology to match contemporary Percutaneous Coronary Intervention (PCI), enabling practitioners to optimize vessel apposition and
Image May 30, 2024 BUELACH, SWITZERLAND Press Release One-Year BIONETIC-I Study Results Show Safety and Effectiveness of Iliac Artery Treatment With BIOTRONIK’s Dynetic-35 Cobalt Chromium Balloon-Expandable Stent System BIOTRONIK announced the presentation of the 12-month results from the BIONETIC-I study this week at LINC 2024. The prospective, international, multicenter single-arm observational study evaluated the treatment of de novo, restenotic or occluded iliac lesions in 160 patients with Rutherford Class 2-6 peripheral artery disease using the Dynetic ®-35 cobalt chromium balloon-expandable stent system. At baseline, 12.5% of enrolled patients had critical limb ischemia, 90% had calcified lesions (30.7% severe calcification), and there was an average of 85.5% stenosis in the target lesion. The primary
Image May 30, 2024 BUELACH, SWITZERLAND Press Release One-Year BIONETIC-I Study Results Show Safety and Effectiveness of Iliac Artery Treatment With BIOTRONIK’s Dynetic-35 Cobalt Chromium Balloon-Expandable Stent System BIOTRONIK announced the presentation of the 12-month results from the BIONETIC-I study this week at LINC 2024. The prospective, international, multicenter single-arm observational study evaluated the treatment of de novo, restenotic or occluded iliac lesions in 160 patients with Rutherford Class 2-6 peripheral artery disease using the Dynetic ®-35 cobalt chromium balloon-expandable stent system. At baseline, 12.5% of enrolled patients had critical limb ischemia, 90% had calcified lesions (30.7% severe calcification), and there was an average of 85.5% stenosis in the target lesion. The primary